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Abstract 
 
Introduction: Heart rate progressively increases with exercise through the function of 
sympathetic and parasympathetic nerves. These nerves control the performance of sinoatrial 
node. Lack of heart rate increase proportionate to the exercise is associated with poor prognosis. 
Moreover, exercise capacity (EC) is considered as a predictor of cardiac events. The current 
study compares these two indices in individuals with and without metabolic syndrome in Isfahan. 
 
Methods: The study was performed on 203 people without metabolic syndrome and 123 patients 
with metabolic syndrome registered in the Isfahan Cohort Study. The demographic data, 
abdominal circumference, blood pressure, height, and weight of the participants were recorded. 
Moreover, the serum triglyceride, fasting blood sugar, total cholesterol, high density lipoprotein 
(HDL), and low density lipoprotein (LDL)levels were measured. Exercise test was carried out 
according to the Bruce standard protocol and heart rate reserve (HRR) and exercise capacity 
(EC) were determined and recorded. The age-adjusted data were analyzed using SPSS software, 
version 15, by the generalized linear model. 
 
Findings: The two groups were not significantly different with regard to HRR (p= 0.27). The 
level of EC in the metabolic syndrome group was significantly lower than that observed in the 
group without metabolic syndrome (p= 0.022).  
 
Conclusion: We could not find relationship between HRR and metabolic syndrome or lack of 
the syndrome. However, the relationship between metabolic syndrome and the EC level indicates 
that in individuals with metabolic syndrome, when EC decreased, HRR did not change 
significantly. (Iranian Heart Journal 2012; 13(2):40-48). 
Keywords: Metabolic syndrome■ Exercise test■ Heart rate reserve■ Insulin resistance. 
 
 
 
 
 
 
 
 
Received  October  2012; Accepted for publication October 2012 
1. Resident of Cardiology, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular research Institute, Isfahan University of Medical 
Sciences, Isfahan, Iran. 
2. Associated Professor of Cardiology, Cardiac Rehabilitation Research Center, Isfahan Cardiovascular research Institute, Isfahan University 
of Medical Sciences, Isfahan, Iran. 
3. Professor of Cardiology, Isfahan Cardiovascular Research Center, Isfahan Cardiovascular research Institute, Isfahan University of 
Medical Sciences, Isfahan, Iran. 
4. Cardiologist, Department of Cardiology, Shahrekord University of Medical Sciences, Shahrekord, Iran. 
5. Psychiatrist, Psychosomatic Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. 
6. Cardiologist, Department of Cardiology, Isfahan University of Medical Sciences, Isfahan, Iran. 
*Correspondence to: Masoumeh Sadeghi. 
Cardiac Rehabilitation Research Center, Isfahan Cardiovascular Research Institute  
Isfahan University of Medical Sciences (http://mui.ac.ir) Isfahan – IRAN. PO BOX: 81465-1148 
Phone: +98 311 3359797 ,Fax: +98 311 3373435 ,Email: sadeghimasoumeh@gmail.com 
 
Ar
chi
ve 
of S
ID
www.SID.ir
Evaluation of Heart Rate Reserve and Exercise Capacity in Individuals…                                                                  E.Aghababaei MD.et al. 
 
41 
 
Introduction 
n 1988, Reaven et al. introduced 
metabolic syndrome as a set of risk 
factors, basically include insulin 
resistance, hypertension (HTN), 
dyslipidemia, and other metabolic disorders, 
which increase the risk of cardiovascular 
diseases (1). Therefore, scientists all around 
the world focused on identification of the 
syndrome to prevent, treat, and lower the 
risk of cardiovascular diseases (2, 3). In 
patients with metabolic syndrome, exercise 
test is helpful in early diagnosis of 
cardiovascular diseases and also prediction 
of the risk of mortality and occurrence of 
cardiovascular events (4-6). Exercise test is 
an affordable, low-risk method, which 
provides valuable information for 
physicians. Two important indices of heart 
rate reserve (HRR) and exercise capacity 
(EC) are among the findings of the test. 
HRR is defined as the increase in the heart 
rate occurred with increase in activity. If the 
value of HRR is not above 85%, it is 
considered to be normal and desirable. The 
value below 85% is associated with poor 
prognosis (7-10). 
EC is the maximal activity an individual can 
do during the exercise test, which is reported 
in metabolic equivalents (METs). One unit 
of MET is equivalent to the activity during 
which 3.5 ml of oxygen is consumed per 
each kilogram of the body weight, and is 
measured in metabolic unit (METs) in each 
minute. According to the studies, these two 
indices are strong predictors for the risk of 
mortality of cardiovascular diseases (11- 
17). However, all patients with metabolic 
syndrome are not at the same risk for 
development of cardiovascular diseases, and 
several factors including race, life style, and 
health culture are effective in this respect 
(18-19). In different studies, researchers 
obtained different results regarding these 
factors (20-26). Furthermore, various 
interventional approaches have different 
effectiveness in reducing the disease risk 
(27-29). It was mentioned that metabolic 
syndrome plays an important role in 
development of cardiovascular diseases, 
which is a major cause of death among 
adults in our country. Moreover, prevalence 
of metabolic syndrome is very high in the 
population under study, and the population 
has differences in ethical and climate 
conditions with other populations studied in 
other countries (30-32). Therefore, in the 
current study, we evaluated the HRR and EC 
of patients with metabolic syndrome and 
compared the values obtained with those of 
the individuals without the syndrome. 
 
Methods 
This cross-sectional study was carried out on 
203 individuals without metabolic syndrome 
and 123 individuals with metabolic 
syndrome who were registered in the Isfahan 
Cohort Study. Isfahan Cohort Study is a 
prospective cohort study, which was started 
in 2002 and will continue until 2012. In the 
cohort study, using multi-stage cluster 
sampling, people with ages above 34 from 
Isfahan, Najafabad, and Arak were selected. 
All the demographic and behavioral data, as 
well as the indices such as blood pressure, 
body mass index, and the results of routine 
blood tests were recorded for all participants 
in the first year of the study. In the 
following, with two-year intervals, the 
occurrence of cardiac infarction, stroke, 
sudden death, and hospitalization were 
asked via telephone calls. Then, in the fifth 
I 
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and sixth years of the follow-up, clinical 
examinations and routine blood tests were 
performed. Further details were published 
by Sarafzadegan et al. in 2003 (33). In 
October 2009, 260 individuals with 
metabolic syndrome and 260 individuals 
without metabolic syndrome from the study 
population of Isfahan Cohort Study who met 
the inclusion criteria of the current study 
were selected using accessibility sampling 
method. Using the telephone number of the 
participants in their file, they were invited to 
participate in the study. Only 123 
individuals with metabolic syndrome and 
203individuals without the syndrome 
participated in all steps of the study and 
other were excluded from the study because 
of not cooperating in fulfillment of the study 
steps. They were invited to the Isfahan 
Cardiovascular Research Center according 
to an appropriate schedule. The participants 
attended an interview and the objectives and 
methodology of the study were explained for 
them, and then after signing a written 
consent, they were included in the study. 
The inclusion criteria for those with 
metabolic syndrome were being affected by 
the syndrome according to the protocol of 
the National Cholesterol Education 
Program/ Adult Treatment Panel (NCEP/ 
ATPIII). In this respect, the individuals 
having three or more of the following items 
were considered to have metabolic 
syndrome: 
1- Waist circumference above 102 cm 
in men and above 88 cm in women, 
2- Blood triglyceride (TG) level ≥ 150 
mg/dl, 
3- Fasting blood sugar (FBS)≥ 110 
mg/dl, 
4- High density lipoprotein (HDL) level 
≤ 40 mg/dl in men and ≤ 50 mg/dl in 
women, and 
5- Systolic blood pressure (SBP) ≥ 135 
mmHg or diastolic blood pressure 
(DBP) ≥ 85 mmHg (34). 
The control group members were also 
selected from the same population in the 
Isfahan Cohort Study, and were included 
after matching for gender, age, and not 
being affected by metabolic syndrome. The 
exclusion criteria were 1- not being able to 
perform the exercise test; 2- presence of an 
absolute contraindication for performance of 
exercise test, for instance myocardial 
infarction in the recent two days, advanced 
heart block, acute pulmonary emboli, 
uncontrolled hypertension, acute 
myocarditis, severe aortic valve stenosis, or 
uncompensated cardiac failure; 3- 
pregnancy; and 4- not being willing to 
attend the study (4). The participants 
referred to the Isfahan Cardiovascular 
Research Center for the examinations at 12-
hour fasting state. After carrying out general 
physical examination and blood sampling, 
the waist circumference, blood pressure, 
weight, and height were measured according 
to the international standards (35). The TG 
and total cholesterol (TC) levels were 
determined using the enzymatic method by 
Autoanalyzer Hitachi 902. Moreover, HDL 
level was measured using heparin-
magnesium precipitation method (36), and 
LDL level was calculated according to the 
Friedewaldformula (37). If the TG level was 
above 400 mg/dl, the LDL level was directly 
measured using a specific kit. The FBS level 
was determined using the enzymatic method 
of glucose oxidase. The 12-lead 
electrocardiogram (ECG) was taken by a 
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trained technician, and the ECG was 
interpreted according to Monica protocol 
(38). Then, exercise test was carried out 
according to Bruce or modified Bruce 
method, and the HRR and EC values were 
determined and recorded in the participants’ 
files.  
The data obtained wereadjusted for age and 
then analyzed by SPSS software, version 15, 
using the generalized linear model. The p 
value < 0.05 was considered to be 
statistically significant. 
The definitions used in the study were as 
follows: 
Hypercholesterolemia: TC> 200 mg/dl when 
using cholesterol lowering agents. 
Hypertriglyceridemia: TG> 200 mg/dl when 
using TG lowering agents. 
Dyslipidemia: Presence of 
hypercholesterolemia or 
hypertriglyceridemia or decreased HDL-C. 
Diabetes: FBS> 126 mg/dl when taking anti-
diabetic drugs. 
Hypertension: SBP> 140 mmHg or DBP> 
90 mmHg when taking at least one anti-
hypertensive drug. 
 
 
Findings 
In total, 326 individuals participated in the 
study, among which 56 men and 67 women 
had metabolic syndrome, and 122 men and 
81 women did not have metabolic 
syndrome. The youngest and oldest 
participants were at the age of 35 and 82, 
respectively. The mean age of those with 
and without metabolic syndrome were 54.29 
and 54.16 years, respectively. 
The values obtained in the examinations for 
weight, waist circumference, SBP, DBP, the 
laboratory findings with regard to the 
gender, and also having metabolic syndrome 
or not, were adjusted by age and provided in 
Table 1. The frequency rates of 
dyslipidemia, diabetes, and hypertension in 
the group with metabolic syndrome were 
higher than those in the group without 
metabolic syndrome (Table 2). 
With regard to the indices of the exercise 
test, the HRR values in the group without 
metabolic syndrome were 75.09% and 
73.17% in men and women, respectively. 
The values in the group with metabolic 
syndrome were 73.52% and 73.13%, 
respectively. The two groups were not 
significantly different in this respect (P 
value= 0.27) (Table 3). 
The mean EC levels in the groups with and 
without metabolic syndrome were 
determined to be 7.56 and 9.3 METs, 
respectively.  The difference between the 
two groups in this respect was statistically 
significant (Table 3). In both groups, the EC 
level in men was higher than that in women, 
and the difference observed between men 
and women in each group was statistically 
significant (Table 3). 
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Table 1: Mean comparison of biochemical and clinical indices in individuals with and without metabolic 
syndrome. 
 Without metabolic 
syndrome 
With metabolic syndrome P value 
Age (years) 
54.1626±8.61947 54.2927±7.60471 0.89 
Waist circumference (cm) 
87.9680±9.43267 98.4179±8.74520 <0.001 
Weight (Kg) 
70.103±11.0853 80.350±12.8479 <0.001 
Triglyceride (mg/dl) 
140.38±61.657 259.99±184.498 <0.001 
Total cholesterol (mg/dl) 
201.17±35.788 217.34±49.596 0.003 
HDL (mg/dl) 
47.91±11.622 41.77±8.674 <0.001 
LDL (mg/dl) 
116.17±24.049 120.12±29.551 0.21 
FBS (mg/dl) 
81.81±9.902 107.13±48.465 <0.001 
Mean SBP (mmHg) 
116.0653±13.69802 130.7378±15.15577 <0.001 
Mean DBP (mmHg) 
76.5271±6.69518 82.8455±8.70495 <0.001 
 
Table 2: Relative frequency of diabetes, dyslipidemia, and hypertension with regard to the gender and having 
or not having metabolic syndrome. 
 Dyslipidemia  Diabetes  Hypertension  
Men with metabolic 
syndrome 
91.10% 32.10% 50% 
Men without 
metabolic 
syndrome 
63.90% 1.60% 9% 
P value <0.001 <0.001 <0.001 
Women with 
metabolic 
syndrome 
89.60% 28.40% 32.80% 
Women without 
metabolic 
syndrome 
63% 1.20% 11.10% 
P value <0.001 <0.001 <0.001 
 
Table 3: Mean comparison of HRR and EC in the groups with and without metabolic syndrome. 
 HRR EC (METs) 
Men without metabolic syndrome 70.09%±7.571% 10.25±10.4 
Women without metabolic syndrome 73.17%±7.601 7.5±1.9 
P value 0.079 0.022 
Men with metabolic syndrome 73.52%±7.685% 8.87±2.3 
Women with metabolic syndrome 73.13%±9.21% 6.7±1.9 
P value  0.805 0.001 
P value between the two groups 0.27 0.022 
Individuals with metabolic syndrome 73.31%±8.522% _ 
Individuals without metabolic 
syndrome 
74.33%±7.622% _ 
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Discussion 
 In the current study, we evaluated two 
important factors for prediction of the risk of 
cardiovascular diseases; namely HRR and 
EC, in individuals with and without 
metabolic syndrome who attended the 
Isfahan Cohort Study. 
In the study, it was observed that the two 
groups were not significantly different in the 
HRR value (p value= 0.27). Moreover, the 
HRR values in men and women of each 
group were not significantly different (p 
values: 0.07 and 0.85 for those with and 
without metabolic syndrome, respectively). 
By reviewing the literature, Regitz-Zagrosek 
has stated the impact of gender differences 
is not definitely confirmed on the prognosis 
of metabolic syndrome (32). 
Moreover, in a review paper, Arena reported 
that the impact of gender differences on 
HRR in normal people is not definitely 
defined (34). Nilsson stated that HRR is 
lower only in women with metabolic 
syndrome (35). 
Exercise Capacity is one of the most 
important prognostic in Exercise test .in 
patients with khnown or suspected  CAD,a 
limited exercise capacity is associated with 
an increased risk of cardiac events. And in 
general ,the more severe the limitation ,the 
worse the CAD  extent and prognosis.7 
Mora and  associates have reported that atter  
adjustment for framing ham Risk score low 
peak METS was significant predictor of 
cardiovascular death . 
Serial comparison of functional capacity in 
individual patients to assess significant 
interval change reguires a carful 
examination of the exercise protocol used 
during both tests,drug therapy and time of 
ingestion ,systemic blood pressure ,and 
other conditions that might influence test 
performance all those variables need to be 
considered before attributing  changes in 
functional capacity to progression of CAD 
or worsening  of left ventvicular function . 
major reductions in exercise capacity 
usually indicate significant worsening of 
cardiovascular status modest changes may 
not(10) 
In selected patients with severe left 
ventricular dysfunction  and symptomatic 
heart failure coronary byposs surjery is 
associated with significant increase in 
exercise capacity when alarje amount of 
dysfunctional but viable myocardium (more 
than 25%of left ventricular moss) is 
revascularized. 
In the current study, the EC values were 
7.56 and 9.3 METs in participants with and 
without metabolic syndrome, respectively 
(p= 0.022). Furthermore, in both groups, the 
EC levels weresignificantly lower in 
women. Considering the EC levelin different 
studies on various populations, the EC level 
have been proposed as a strong predicting 
factor for both genders (9- 17). 
The most notable result of the study is the 
similar values of HRR in individuals with 
and without metabolic syndrome. Also, 
since the Isfahan Cohort Study is in 
progress, the predicting values of HRR in 
the population under study could be 
determined by evaluation of the rate of 
cardiovascular events in future. 
In the study, it was demonstrated that the EC 
level in the groups with metabolic syndrome 
was significantly lower than that in people 
without the syndrome (p= 0.022). This is 
consistent with the findings of previous 
studies. Therefore, it can be concluded that 
in the population under study, the 
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relationship between EC and metabolic 
syndrome is stronger than that for the HRR. 
This would be useful for physicians and 
health planners in making more accurate 
decisions. 
Moreover, the study could serve as a 
foundation for further studies in our 
community on people with metabolic 
syndrome, the relationship between the 
syndrome and cardiovascular diseases, and 
alsothe predicting value of the above-
mentioned indices. 
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